Events B2B Event

B2B Event

BIO CEO & Investor Conference 2027

Trade-orientedMid-size
📅 8 February 2027 – 9 February 📍 New York Marriott Marquis, New York, US ↗ 🏢 Biotechnology Innovation Organization

Premier investor conference connecting C-suite biotech leaders with investors and bankers for partnering, presentations, and therapeutic discussions.

Exhibitor mix: Company presentations categorized by therapeutics,, and corporate type.

Filter this event to your ICP.

Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.

Request intelligence →

Delivery within 24 hours · $1,250

⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.

Venue

New York Marriott Marquis

Hotel venue · 9,290 m² · 5 halls · ~2,800 people

A large, 1,971-room hotel in Manhattan, NYC, with over 100,000 sq ft of event space refreshed in 2021. Features extensive meeting rooms and ballrooms, including the 29,000 sq ft Broadway Ballroom, suitable for large conferences, exhibitions, and gala events in Times Square.

📍 1535 Broadway, 10036 New York, US

Operated by Marriott International

28 events tracked at this venue → Venue website ↗

Organizer

Biotechnology Innovation Organization

Nonprofit · Washington, United States · Founded 1993

The premier global trade association representing biotechnology companies, industry leaders, and state biotechnology groups.

Runs 3 events → LinkedIn ↗

Why people attend

Discover, connect with, and fund established and emerging publicly traded and private biotech companies via one-on-one partnering and company presentations.

Exhibitor categories

Biotech ExecutivesVenture InvestorsBankersCorporate Licensing Professionals

Sample matches

Filtered to a Series-B SaaS ICP. Your filter will be different.

Sample Match A

example.com

91 — High
Enterprise SaaS200–500 employeesAmsterdam, NL

"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."

Sample Match B

example.io

79 — Medium
Cloud platform50–200 employeesLondon, UK

"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."

████████ ██████

████████.io

██ — Medium
████████████ 200–500 employees ████, ██

"████████████████████████████████████████."

Submit your ICP
to unlock all matches

Request intelligence →

████████ ██████

████████.io

██ — Medium
████████████ 200–500 employees ████, ██

"████████████████████████████████████████."

Submit your ICP
to unlock all matches

Request intelligence →

Speakers

303 speakers at BIO CEO & Investor Conference

R

Roger Wyse

Founder · Spruce Capital

"GreenTech Investor Sessions"

biotechnology investmentcleantechventure capital
M

Michael Krel

Senior Associate · Sofinnova Partners

"GreenTech Investor Sessions"

biotechnology investmentcleantechventure capital
N

Neil Cameron

Investment Director · Emerald Technology Ventures

"GreenTech Investor Sessions"

biotechnology investmentcleantechventure capital
T

Thomas Huot

Managing Director · Vantagepoint Capital Partners

"GreenTech Investor Sessions"

biotechnology investmentcleantechventure capital
M

Mario Portela

Managing Director · Texas Pacific Group

"GreenTech Investor Sessions"

biotechnology investmentcleantechventure capital
J

John Cumbers

Founder · SynBioBeta

"Outer Space: The Next Biotech Frontier"

Synthetic Biology

Also speaking at BIO Middle East 2026

C

Catherine “Cady” Coleman

Astronaut · NASA

"Outer Space: The Next Biotech Frontier"

space biotechnologysynthetic biologymicro-organisms
A

Amor Menezes

Postdoctoral Scholar · University of California, Berkeley

"Outer Space: The Next Biotech Frontier"

space biotechnologysynthetic biologymicro-organisms
T

Todd Peterson

Chief Technology Officer · Synthetic Genomics

"Outer Space: The Next Biotech Frontier"

space biotechnologysynthetic biologymicro-organisms

Also speaking at North America Energy Capital Assembly

M

Mark Blenner

Assistant Professor of Chemical & Biomolecular Engineering · Clemson University

"Outer Space: The Next Biotech Frontier"

space biotechnologysynthetic biologymicro-organisms
D

Dan Cummings

Chief Executive Officer · Guidewire Strategies

"Overcoming Challenges to Biorefinery Scale Up"

biorefinery scale upadvanced biofuelsprocess control
A

Anthony Bresin

Chief Scientific Officer · ARD

"Overcoming Challenges to Biorefinery Scale Up"

biorefinery scale upadvanced biofuelsprocess control

Also speaking at Advanced Fermentation Technology (AFT)

J

Jeff Lievense

Senior Engineering Fellow · Genomatica

"Overcoming Challenges to Biorefinery Scale Up"

biorefinery scale upadvanced biofuelsprocess control
D

Dennis McGinn

Assistant Secretary of the Navy - Energy, Installations and Environment · U.S. Navy

"Overcoming Challenges to Biorefinery Scale Up"

biorefinery scale upadvanced biofuelsprocess control
A

Alan Propp

Business Development Manager · Merrick & Company

"Overcoming Challenges to Biorefinery Scale Up"

biorefinery scale upadvanced biofuelsprocess control
J

Joachim Schulze

Head of Biotechnology · ThyssenKrupp Solutions

"Overcoming Challenges to Biorefinery Scale Up"

biorefinery scale upadvanced biofuelsprocess control

+ 287 more speakers at this event.

More B2B Event events

B2B Event

FASEB Science Research Conference: Phospholipids in Aging and Disease

Scottsdale, US Jul 2026

Consumer Goods

The Children's Show

New York, US Jul 2026

B2B Event

SACUBO College Business Management Institute

Lexington, US Jul 2026

Transportation & Mobility

International Conference

Philadelphia, US Jul 2026

More events in United States

United States event calendar

Frequently asked questions

When is BIO CEO & Investor Conference?+
BIO CEO & Investor Conference takes place on 8 February 2027 to 9 February 2027.
Where is BIO CEO & Investor Conference held?+
BIO CEO & Investor Conference is held at New York Marriott Marquis, New York, US.
Who organises BIO CEO & Investor Conference?+
BIO CEO & Investor Conference is organised by Biotechnology Innovation Organization.

Ready to map BIO CEO & Investor Conference?

Request intelligence →